255 related articles for article (PubMed ID: 12397728)
1. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
[TBL] [Abstract][Full Text] [Related]
2. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
3. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
4. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
5. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
[TBL] [Abstract][Full Text] [Related]
6. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer.
Basoglu M; Yildirgan MI; Taysi S; Yilmaz I; Kiziltunc A; Balik AA; Celebi F; Atamanalp SS
J Surg Oncol; 2003 Jul; 83(3):180-4. PubMed ID: 12827689
[TBL] [Abstract][Full Text] [Related]
7. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
10. Second primary cancer after surgery for colorectal cancer without lymph node metastasis.
Ikeda Y; Kishihara F; Saitsu H; Saku M; Maehara Y
Hepatogastroenterology; 2007; 54(79):1962-5. PubMed ID: 18251139
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor expression and metastatic potential of colorectal cancer.
Shigemori C; Wada H; Matsumoto K; Shiku H; Nakamura S; Suzuki H
Thromb Haemost; 1998 Dec; 80(6):894-8. PubMed ID: 9869156
[TBL] [Abstract][Full Text] [Related]
12. Altering trend of clinical characteristics of colorectal cancer: a report of 3,607 cases.
Jiang SX; Wang XS; Geng CH; Wang GY
Ai Zheng; 2009 Jan; 28(1):54-6. PubMed ID: 19448417
[TBL] [Abstract][Full Text] [Related]
13. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
15. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
[TBL] [Abstract][Full Text] [Related]
16. Progressive loss of perivascular nerves adjacent to colorectal cancer.
Chamary VL; Robson T; Loizidou M; Boulos PB; Burnstock G
Eur J Surg Oncol; 2000 Sep; 26(6):588-93. PubMed ID: 11034811
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
18. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of nucleolar organiser regions in colorectal cancer: a 5-year follow-up study.
Joyce WP; Fynes M; Moran KT; Gough DB; Dervan P; Gorey TF; Fitzpatrick JM
Ann R Coll Surg Engl; 1992 May; 74(3):172-6; discussion 176-7. PubMed ID: 1616259
[TBL] [Abstract][Full Text] [Related]
20. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
Arango D; Laiho P; Kokko A; Alhopuro P; Sammalkorpi H; Salovaara R; Nicorici D; Hautaniemi S; Alazzouzi H; Mecklin JP; Järvinen H; Hemminki A; Astola J; Schwartz S; Aaltonen LA
Gastroenterology; 2005 Sep; 129(3):874-84. PubMed ID: 16143127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
